SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Heptares and Takeda Pharmaceutical Co. Ltd. Initiate Drug Discovery Collaboration Focused on GPCR Linked to CNS Disorders; Heptares to Get GBP 4.5 Million Upfront and Up to GBP 60.5 Million